Abstract:Motivation: Identifying and developing novel therapeutic effects for existing drugs contributes to reduction of drug development costs. Most of the previous methods focus on integration of the heterogeneous data of drugs and diseases from multiple sources for predicting the candidate drug-disease associations. However, they fail to take the prior knowledge of drugs and diseases and their sparse characteristic into account. It is essential to develop a method that exploits the more useful information to predict the reliable candidate associations. Results: We present a method based on non-negative matrix factorization, DisDrugPred, to predict the drug-related candidate disease indications. A new type of drug similarity is firstly calculated based on their associated diseases. DisDrugPred completely integrates two types of disease similarities, the associations between drugs and diseases, and the various similarities between drugs from different levels including the chemical structures of drugs, the target proteins of drugs, the diseases associated with drugs and the side effects of drugs. The prior knowledge of drugs and diseases and the sparse characteristic of drug-disease associations provide a deep biological perspective for capturing the relationships between drugs and diseases. Simultaneously, the possibility that a drug is associated with a disease is also dependant on their projections in the low-dimension feature space. Therefore, DisDrugPred deeply integrates the diverse prior knowledge, the sparse characteristic of associations and the projections of drugs and diseases. DisDrugPred achieves superior prediction performance than several state-of-the-art methods for drug-disease association prediction. During the validation process, DisDrugPred also can retrieve more actual drug-disease associations in the top part of prediction result which often attracts more attention from the biologists. Moreover, case studies on five drugs further confirm DisDrugPred's ability to discover potential candidate disease indications for drugs.

Computational Drug Repositioning Using Meta-Path-based Semantic Network Analysis.

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

Computational Drug Repositioning with Random Walk on a Heterogeneous Network

Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm

HeTDR: Drug Repositioning Based on Heterogeneous Networks and Text Mining

Author Correction: Prediction of New Drug Indications Based on Clinical Data and Network Modularity

In Silico Drug Repositioning Using Deep Learning and Comprehensive Similarity Measures

Drug Repositioning Based on the Enhanced Message Passing and Hypergraph Convolutional Networks

Drug repositioning based on the heterogeneous information fusion graph convolutional network

Predicting drug-disease associations by network embedding and biomedical data integration.

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

A Pathway Profile-Based Method for Drug Repositioning

Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.

In silico drug repositioning based on drug-miRNA associations

Computational Drug Repositioning Using Collaborative Filtering Via Multi-Source Fusion

Drug Repositioning By Kernel-Based Integration Of Molecular Structure, Molecular Activity, And Phenotype Data

Semi-supervised Graph Cut Algorithm for Drug Repositioning by Integrating Drug, Disease and Genomic Associations.

Drug Repositioning Through Integration of Prior Knowledge and Projections of Drugs and Diseases

deepDR: a network-based deep learning approach to in silico drug repositioning

A Novel Drug Repositioning Approach Based on Collaborative Metric Learning

Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity